Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
AbbVie
ABBV
|
+$3.06B |
| 2 |
Pfizer
PFE
|
+$1.93B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.67B |
| 4 |
Morgan Stanley
MS
|
+$1.59B |
| 5 |
Constellation Energy
CEG
|
+$1.25B |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$2.84B |
| 2 |
Exelon
EXC
|
+$2.5B |
| 3 |
Gilead Sciences
GILD
|
+$1.81B |
| 4 |
Union Pacific
UNP
|
+$1.68B |
| 5 |
Microsoft
MSFT
|
+$1.33B |
Sector Composition
| 1 | Technology | 23.02% |
| 2 | Financials | 14.78% |
| 3 | Healthcare | 14.09% |
| 4 | Communication Services | 11.78% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Capital Group Global Growth Equity ETF
CGGO
$7.11B
| $22.7M | 0.01% |
+935,000
| New | +$22.7M |
|
402
Advanced Energy
AEIS
$5.91B
| $22.5M | 0.01% |
261,162
-519,349
| -67% | -$44.7M |
|
403
Alibaba
BABA
$377B
| $22.4M | 0.01% |
204,535
+2,714
| +1% | +$297K |
|
404
XPEL
XPEL
$950M
| $21.9M | 0.01% |
+416,678
| New | +$21.9M |
|
405
Insulet
PODD
$24B
| $20.8M | ﹤0.01% |
77,900
| – | – |
|
406
Live Oak Bancshares
LOB
$1.67B
| $20.4M | ﹤0.01% |
400,900
| – | – |
|
407
Thermo Fisher Scientific
TMO
$179B
| $19.6M | ﹤0.01% |
33,162
-598,086
| -95% | -$353M |
|
|
APTV.PRA
408
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
| $19.3M | ﹤0.01% |
+141,300
| New | +$19.3M |
|
409
Kinsale Capital Group
KNSL
$9.88B
| $18.7M | ﹤0.01% |
82,000
+33,007
| +67% | +$7.53M |
|
410
Marqeta
MQ
$2.6B
| $18.3M | ﹤0.01% |
+1,653,393
| New | +$18.3M |
|
411
iShares MSCI ACWI ETF
ACWI
$22.7B
| $16.2M | ﹤0.01% |
159,877
-280,802
| -64% | -$28.5M |
|
412
Vodafone
VOD
$28.4B
| $14.9M | ﹤0.01% |
+898,211
| New | +$14.9M |
|
|
EVA
413
DELISTED
Enviva Inc.
EVA
| $14.8M | ﹤0.01% |
+186,466
| New | +$14.8M |
|
414
BHP
BHP
$139B
| $13.8M | ﹤0.01% |
+198,067
| New | +$13.8M |
|
415
Fair Isaac
FICO
$37.3B
| $13.6M | ﹤0.01% |
29,100
| – | – |
|
416
Blend Labs
BLND
$1.1B
| $13.3M | ﹤0.01% |
2,330,432
+193,550
| +9% | +$1.1M |
|
|
KRTX
417
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $13M | ﹤0.01% |
102,875
+24,275
| +31% | +$3.08M |
|
418
MaxLinear
MXL
$1.45B
| $12.9M | ﹤0.01% |
220,498
+49,008
| +29% | +$2.86M |
|
419
Sweetgreen
SG
$993M
| $12.8M | ﹤0.01% |
400,000
| – | – |
|
420
Deere & Co
DE
$127B
| $10M | ﹤0.01% |
24,163
+60
| +0.2% | +$24.9K |
|
421
Sana Biotechnology
SANA
$831M
| $9.91M | ﹤0.01% |
1,199,305
-695
| -0.1% | -$5.74K |
|
422
SPDR S&P 500 ETF Trust
SPY
$670B
| $9.79M | ﹤0.01% |
21,348
-9,490
| -31% | -$4.35M |
|
423
Cenovus Energy
CVE
$30.9B
| $9.52M | ﹤0.01% |
570,800
| – | – |
|
424
Grifois
GRFS
$6.55B
| $8.5M | ﹤0.01% |
727,236
-91,276
| -11% | -$1.07M |
|
425
WPP
WPP
$5.74B
| $7.9M | ﹤0.01% |
114,486
+4,587
| +4% | +$317K |
|